InvestorsHub Logo
Followers 839
Posts 120405
Boards Moderated 18
Alias Born 09/05/2002

Re: axelvento post# 12200

Friday, 11/11/2022 6:10:04 PM

Friday, November 11, 2022 6:10:04 PM

Post# of 13582
That's bullish for ENTA's RSV therapeutics (non-vaccine) program.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News